Genetics of eating disorders

Current Psychiatry Reports

Volumn 15, Issue 12, 2013, Pages

  Hinney, Anke ^a   Volckmar, Anna Lena ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

5 HT2A receptor gene; Eating disorders; Genome wide association studies; GWAS; Melanocortin 4 receptor gene; Psychiatry

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; DOPAMINE 2 RECEPTOR; LEPTIN; SEROTONIN 2A RECEPTOR; SEROTONIN TRANSPORTER; TRYPTOPHAN HYDROXYLASE 2;

5 HT2A RECEPTOR GENE; 5 HTT GENE; ANOREXIA NERVOSA; ANXIETY DISORDER; ARTICLE; BDNF GENE; BULIMIA; COMORBIDITY; DIZYGOTIC TWINS; DOPAMINERGIC SYSTEM; DRD2 RECEPTOR GENE; EPIGENETICS; FIRST DEGREE RELATIVE; FTO GENE; GENE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HERITABILITY; HUMAN; LEPTIN GENE; MONOZYGOTIC TWINS; MOOD DISORDER; OBESITY; PUBERTY; REWARD; SEROTONINERGIC SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; TPH2 GENE; UNDERWEIGHT; ANOREXIA; GENETICS; TWINS;

ANOREXIA; BULIMIA NERVOSA; GENOME-WIDE ASSOCIATION STUDY; HUMANS; TWIN STUDIES AS TOPIC;

EID: 84886970794     PISSN: 15233812     EISSN: 15351645     Source Type: Journal    
DOI: 10.1007/s11920-013-0423-y     Document Type: Article

References (130)

1. American Psychiatric Association (APA). Diagnostic and statistical manual of mental disorders. 5th ed. Washington: APA; 2013.
2. World Health Organization (WHO). ICD-10. International classification of mental and behavioural disorders. Clinical description and diagnostic guidelines. Geneva: WHO; 1998.
3. Hoek HW. Incidence, prevalence and mortality of anorexia nervosa and other eating disorders. Curr Opin Psychiatry. 2006;19:389-94. (Pubitemid 44317865)
4. Hudson JI, Hiripi E, Pope Jr HG, et al. The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biol Psychiatry. 2007;61:348-58. (Pubitemid 46108682)
5. Smink FR, van Hoeken D, Hoek HW. Epidemiology of eating disorders: incidence, prevalence and mortality rates. Curr Psychiatry Rep. 2012;14:406-14.
6. Trace SE, Baker JH, Peñas-Lledó E, et al. The genetics of eating disorders. Annu Rev Clin Psychol. 2013;9:589-620.
7. Javaras KN, Laird NM, Reichborn-Kjennerud T, et al. Familiality and heritability of binge eating disorder: results of a case-control family study and a twin study. Int J Eat Disord. 2008;41:174-9. (Pubitemid 351294991)
8. Mitchell KS, Neale MC, Bulik CM, et al. Binge eating disorder: a symptom-level investigation of genetic and environmental influences on liability. Psychol Med. 2010;40:1899-906.
9. Keski-Rahkonen A, Hoek HW, Susser ES, et al. Epidemiology and course of anorexia nervosa in the community. Am J Psychiatry. 2007;164:1259-65. (Pubitemid 47292416)
10. Bulik CM, Sullivan PF, Wade TD, et al. Twin studies of eating disorders: a review. Int J Eat Disord. 2000;27:1-20. (Pubitemid 30013230)
11. Klump KL, Holly A, Iaconom WG, et al. Physical similarity and twin resemblance for eating attitudes and behaviors: a test of the equal environments assumption. Behav Genet. 2000;30:51-8. (Pubitemid 30602874)
12. Klump KL, Kaye WH, Strober M. The evolving genetic foundations of eating disorders. Psychiatr Clin North Am. 2001;24:215-25. (Pubitemid 32523870)
13. Klump KL, Miller KB, Keel PK, et al. Genetic and environmental influences on anorexia nervosa syndromes in a population-based twin sample. Psychol Med. 2001;31:737-40. (Pubitemid 32421974)
14. Klump KL, Wonderlich S, Lehoux P, et al. Does environment matter? A review of nonshared environment and eating disorders. Int J Eat Disord. 2002;31:118-35. (Pubitemid 34178253)
15. • Fairburn CG, Harrison PJ. Eating disorders. Lancet. 2003;361:407-16. Comprehensive review on eating disorders. (Pubitemid 36164979)
16. Kendler KS, Walters EE, Neale MC, et al. The structure of the genetic and environmental risk factors for six major psychiatric disorders in women. Phobia, generalized anxiety disorder, panic disorder, bulimia, major depression, and alcoholism. Arch Gen Psychiatry. 1995;52:374-83.
17. Kipman A, Gorwood P, Mouren-Siméoni MC, et al. Genetic factors in anorexia nervosa. Eur Psychiatry. 1999;14:189-98. (Pubitemid 36193293)
18. Bulik CM, Sullivan PF, Kendler KS. Heritability of binge-eating and broadly defined bulimia nervosa. Biol Psychiatry. 1998;44:1210-8. (Pubitemid 29015860)
19. Wade TD, Bulik CM, Neale M, et al. Anorexia nervosa and major depression: shared genetic and environmental risk factors. Am J Psychiatry. 2000;157:469-71. (Pubitemid 30145940)
20. Kortegaard LS, Hoerder K, Joergensen J, et al. A preliminary population-based twin study of self-reported eating disorder. Psychol Med. 2001;31:361-5. (Pubitemid 32166401)
21. Walters EE, Kendler KS. Anorexia nervosa and anorexic-like syndromes in a population-based female twin sample. Am J Psychiatry. 1995;152:64-71.
22. • Bulik CM, Thornton LM, Root TL, et al. Understanding the relation between anorexia nervosa and bulimia nervosa in a Swedish national twin sample. Biol Psychiatry. 2010;67:71-7. Heritability estimation and analysis of the genetic overlap between AN and BN in a large twin sample.
23. Strober M, Freeman R, Lampert C, et al. Controlled family study of anorexia nervosa and bulimia nervosa: evidence of shared liability and transmission of partial syndromes. Am J Psychiatry. 2001;157:393-401. (Pubitemid 30145925)
24. Hinney A, Remschmidt H, Hebebrand J. Candidate gene polymorphisms in eating disorders. Eur J Pharmacol. 2000;410:147-59. (Pubitemid 32008140)
25. Hinney A, Scherag S, Hebebrand J. Genetic findings in anorexia and bulimia nervosa. Prog Mol Biol Transl Sci. 2010;94:241-70.
26. Scherag S, Hebebrand J, Hinney A. Eating disorders: the current status of molecular genetic research. Eur Child Adolesc Psychiatry. 2010;19:211-26.
27. Barry VC, Klawans HL. On the role of dopamine in the pathophysiology of anorexia nervosa. J Neural Transm. 1976;38:107-22.
28. Golden NH, Shenker IR. Amenorrhea in anorexia nervosa. Neuroendocrine control of hypothalamic dysfunction. Int J Eat Disord. 1994;16:53-60. (Pubitemid 24200160)
29. • Kaye WH, Gwirtsman HE, George DT, et al. Altered serotonin activity in anorexia nervosa after long-term weight restoration. Does elevated cerebrospinal fluid 5-hydroxyindoleacetic acid level correlate with rigid and obsessive behavior? Arch Gen Psychiatry. 1991;48:556-62. First report implicating the relevance of the serotonergic system as a trait marker in AN.
30. • Kaye WH, Greeno CG, Moss H, et al. Alterations in serotonin activity and psychiatric symptoms after recovery from bulimia nervosa. Arch Gen Psychiatry. 1998;55:927-35. First report implicating the relevance of the serotonergic system as a trait marker in BN. (Pubitemid 28465783)
31. • Kaye WH, Frank GK, McConaha C. Altered dopamine activity after recovery from restricting-type anorexia nervosa. Neuropsychopharmacology. 1999;21:503-6. First report implicating the relevance of the dopaminergic system as a trait marker in AN. (Pubitemid 29414794)
32. Kaye WH, Klump KL, Frank GK, et al. Anorexia and bulimia nervosa. Annu Rev Med. 2000;51:299-313. (Pubitemid 30216039)
33. Kaye WH, Lilenfeld LR, Berrettini WH, et al. A search for susceptibility loci for anorexia nervosa: methods and sample description. Biol Psychiatry. 2000;47:794-803. (Pubitemid 30254052)
34. Kaye WH, Bulik CM, Thornton L, et al. Comorbidity of anxiety disorders with anorexia and bulimia nervosa. Am J Psychiatry. 2004;161:2215-21. (Pubitemid 39587286)
35. Kaye WH, Fudge JL, Paulus M. New insights into symptoms and neurocircuit function of anorexia nervosa. Nat Rev Neurosci. 2009;10:573-84.
36. Keating C. Theoretical perspective on anorexia nervosa: the conflict of reward. Neurosci Biobehav Rev. 2010;34:73-9.
37. Wagner A, Aizenstein H, Venkatraman VK, et al. Altered reward processing in women recovered from anorexia nervosa. Am J Psychiatry. 2007;164:1842-9. (Pubitemid 351739237)
38. Wagner A, Aizenstein H, Venkatraman VK, et al. Altered striatal response to reward in bulimia nervosa after recovery. Int J Eat Disord. 2010;43:289-94.
39. Vaz-Leal FJ, Rodríguez Santos L, García-Herráiz MA, et al. Bulimia nervosa with history of anorexia nervosa: Could the clinical subtype of anorexia have implications for clinical status and treatment response? Int J Eat Disord. 2011;44:212-9.
40. Fairburn CG, Cooper Z, Doll HA, et al. Risk factors for anorexia nervosa: three integrated case-control comparisons. Arch Gen Psychiatry. 1999;56:468-76. (Pubitemid 29215436)
41. • Hebebrand J, Remschmidt H. Anorexia nervosa viewed as an extreme weight condition: genetic implications. Hum Genet. 1995;95:1-11. First report on the importance of body weight in an eating disorder.
42. Rosenkranz K, Hinney A, Ziegler A, et al. Systematic mutation screening of the estrogen receptor beta gene in probands of different weight extremes: identification of several genetic variants. J Clin Endocrinol Metab. 1998;83:4524-7. (Pubitemid 29100162)
43. Versini A, Ramoz N, Le Strat Y, et al. Estrogen receptor 1 gene (ESR1) is associated with restrictive anorexia nervosa. Neuropsychopharmacology. 2010;35:1818-25.
44. Blundell JE, Lawton CL, Halford JC. Serotonin, eating behavior, and fat intake. Obes Res. 1995;3:471S-6S.
45. Halford JC, Blundell JE. Separate systems for serotonin and leptin in appetite control. Ann Med. 2000;32:222-32. (Pubitemid 30237567)
46. Wurtman RJ, Wurtman JJ. Brain Serotonin, Carbohydrate-craving, obesity and depression. Adv Exp Med Biol. 1996;398:35-41. (Pubitemid 126439514)
47. Jimerson DC, Lesem MD, Kaye WH, et al. Low serotonin and dopamine metabolite concentrations in cerebrospinal fluid from bulimic patients with frequent binge episodes. Arch Gen Psychiatry. 1992;49:132-8.
48. Brewerton TD, Jimerson DC. Studies of serotonin function in anorexia nervosa. Psychiatry Res. 1996;62:31-42. (Pubitemid 26153325)
49. Gorwood P, Adès J, Bellodi L, et al. The 5-HT(2A) -1438G/A polymorphism in anorexia nervosa: a combined analysis of 316 trios from six European centres. Mol Psychiatry. 2002;7:90-4. (Pubitemid 34087885)
50. Gorwood P. Eating disorders, serotonin transporter polymorphisms and potential treatment response. Am J Pharmacogenomics. 2004;4:9-17. (Pubitemid 38325701)
51. Calati R, De Ronchi D, Bellini M, et al. The 5-HTTLPR polymorphism and eating disorders: a meta-analysis. Int J Eat Disord. 2011;44:191-9.
52. Castellini G, Ricca V, Lelli L, et al. Association between serotonin transporter gene polymorphism and eating disorders outcome: a 6-year follow-up study. Am J Med Genet Neuropsychiatr Genet. 2012;159B:491-500.
53. Slof-Op 't Landt MC, Meulenbelt I, Bartels M, et al. Association study in eating disorders: TPH2 associates with anorexia nervosa and self-induced vomiting. Genes Brain Behav. 2011;10:236-43.
54. Slof-Op't Landt MC, Bartels M, Middeldorp CM, et al. Genetic variation at the TPH2 gene influences impulsivity in addition to eating disorders. Behav Genet. 2013;43:24-33.
55. Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet. 1995;11:241-7.
56. Bergen AW, Yeager M, Welch RA, et al. Association of multiple DRD2 polymorphisms with anorexia nervosa. Neuropsychopharmacology. 2005;30:1703-10. (Pubitemid 43086027)
57. Davis C, Levitan RD, Yilmaz Z, et al. Binge eating disorder and the dopamine D2 receptor: genotypes and sub-phenotypes. Prog Neuropsychopharmacol Biol Psychiatry. 2012;38:328-33.
58. Bachner-Melman R, Lerer E, et al. Anorexia nervosa, perfectionism, and dopamine D4 receptor (DRD4). Am J Med Genet B Neuropsychiatr Genet. 2007;144B:748-56. (Pubitemid 47417203)
59. Ahima RS, Prabakaran D, Mantzoros C, et al. Role of leptin in the neuroendocrine response to fasting. Nature. 1996;382:250-2. (Pubitemid 26251358)
60. • Hebebrand J, van der Heyden J, Devos R, et al. Plasma concentrations of obese protein in anorexia nervosa. Lancet. 1995;346:1624-5. First description of the extremely low leptin levels in patients with AN. (Pubitemid 26002165)
61. Hebebrand J, Müller TD, Holtkamp K, et al. The role of leptin in anorexia nervosa: clinical implications. Mol Psychiatry. 2007;12:23-35. (Pubitemid 44973660)
62. Hebebrand J, Blum WF, Barth N, et al. Leptin levels in patients with anorexia nervosa are reduced in the acute stage and elevated upon short-term weight restoration. Mol Psychiatry. 1997;2:330-4. (Pubitemid 27450316)
63. Grinspoon S, Gulick T, Askari H, et al. Serum leptin levels in women with anorexia nervosa. J Clin Endocrinol Metab. 1996;81:3861-3. (Pubitemid 26380387)
64. Haas V, Onur S, Paul T, et al. Leptin and body weight regulation in patients with anorexia nervosa before and during weight recovery. Am J Clin Nutr. 2005;81:889-96. (Pubitemid 41724999)
65. Holtkamp K, Mika C, Grzella I, et al. Reproductive function during weight gain in anorexia nervosa. Leptin represents a metabolic gate to gonadotropin secretion. J Neural Transm. 2003;110:427-35. (Pubitemid 36428390)
66. Frey J, Hebebrand J, Müller B, et al. Reduced body fat in long-term followed-up female patients with anorexia nervosa. J Psychiatr Res. 2000;34:83-8. (Pubitemid 30006943)
67. Haluzík M, Papezová M, Nedvídková J, et al. Serum leptin levels in patients with anorexia nervosa before and after partial refeeding, relationships to serum lipids and biochemical nutritional parameters. Physiol Res. 1999;48:197-202. (Pubitemid 29317815)
68. Gendall KA, Kaye WH, Altemus M, et al. Leptin, neuropeptide Y, and peptide YY in long-term recovered eating disorder patients. Biol Psychiatry. 1999;46:292-9. (Pubitemid 29320082)
69. Hinney A, Bornscheuer A, Depenbusch M, et al. No evidence for involvement of the leptin gene in anorexia nervosa, bulimia nervosa, underweight or early onset extreme obesity: identification of two novel mutations in the coding sequence and a novel polymorphism in the leptin gene linked upstream region. Mol Psychiatry. 1998;3:539-43.
70. Quinton ND, Meechan DW, Brown K, et al. Single nucleotide polymorphisms in the leptin receptor gene: studies in anorexia nervosa. Psychiatr Genet. 2004;14:191-4. (Pubitemid 40054343)
71. • Brandys MK, van Elburg AA, Loos RJ, et al. Are recently identified genetic variants regulating BMI in the general population associated with anorexia nervosa? Am J Med Genet B Neuropsychiatr Genet. 2010;153B:695-9. Analyses of GWAS-derived obesity genes in AN.
72. Farooqi IS, Yeo GS, Keogh JM, et al. Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. J Clin Invest. 2000;106:271-9. (Pubitemid 30483131)
73. Hinney A, Schmidt A, Nottebom K, et al. Several mutations in the melanocortin-4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans. J Clin Endocrinol Metab. 1999;84:1483-6. (Pubitemid 30644420)
74. Hinney A, Hohmann S, Geller F, et al. Melanocortin-4 receptor gene: case-control study and transmission disequilibrium test confirm that functionally relevant mutations are compatible with a major gene effect for extreme obesity. J Clin Endocrinol Metab. 2003;88:4258-67. (Pubitemid 37153729)
75. Hinney A, Bettecken T, Tarnow P, et al. Prevalence, spectrum, and functional characterization of melanocortin-4 receptor gene mutations in a representative population-based sample and obese adults from Germany. J Clin Endocrinol Metab. 2006;91:1761-9.
76. Vaisse C, Clement K, Guy-Grand B, et al. A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat Genet. 1998;20:113-4. (Pubitemid 28455439)
77. Vaisse C, Clement K, Durand E, et al. Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J Clin Invest. 2000;106:253-62. (Pubitemid 30483129)
78. Yeo GS, Farooqi IS, Aminian S, et al. A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat Genet. 1998;20:111-2. (Pubitemid 28455438)
79. • Hebebrand J, Fichter M, Gerber G, et al. Genetic predisposition to obesity in bulimia nervosa: a mutation screen of the melanocortin-4 receptor gene. Mol Psychiatry. 2002;7:647-51. Detection of an "obesity mutation" in a patient with BN.
80. Branson R, Potoczna N, Kral JG, et al. Binge eating as a major phenotype of melanocortin 4 receptor gene mutations. N Engl J Med. 2003;348:1096-103. (Pubitemid 36337320)
81. Potoczna N, Branson R, Kral JG, et al. Gene variants and binge eating as predictors of comorbidity and outcome of treatment in severe obesity. J Gastrointest Surg. 2004;8:971-81.
82. Geller F, Reichwald K, Dempfle A, et al. Melanocortin-4 receptor gene variant I103 is negatively associated with obesity. Am J Hum Genet. 2004;74:572-81. (Pubitemid 38325928)
83. Wang D, Ma J, Zhang S, et al. Association of the MC4R V103I polymorphism with obesity: a Chinese Case-control study and meta-analysis in 55,195 individuals. Obesity (Silver Spring). 2010;18:573-9.
84. Herpertz S, Siffert W, Hebebrand J. Binge eating as a phenotype of melanocortin 4 receptor gene mutations. N Engl J Med. 2003;349:606-9. (Pubitemid 36951374)
85. Hebebrand J, Geller F, Dempfle A, et al. Binge-eating episodes are not characteristic of carriers of melanocortin-4 receptor gene mutations. Mol Psychiatry. 2004;9:796-800. (Pubitemid 39107968)
86. Valette M, Bellisle F, Carette C, et al. Eating behaviour in obese patients with melanocortin-4 receptor mutations: a literature review. Int J Obes (Lond). 2013;37:1027-35.
87. Ribasés M, Gratacòs M, Fernández-Aranda F, et al. Association of BDNF with restricting anorexia nervosa and minimum body mass index: a family-based association study of eight European populations. Eur J Hum Genet. 2005;13:428-34. (Pubitemid 40520933)
88. Dmitrzak-Weglarz M, Skibinska M, Slopien A, et al. BDNF Met66 allele is associated with anorexia nervosa in the Polish population. Psychiatr Genet. 2007;17:245-6. (Pubitemid 47051910)
89. Gelegen C, van den Heuvel J, Collier DA, et al. Dopaminergic and brain-derived neurotrophic factor signalling in inbred mice exposed to a restricted feeding schedule. Genes Brain Behav. 2008;7:552-9. (Pubitemid 351991493)
90. Ribasés M, Gratacòs M, Fernández-Aranda F, et al. Association of BDNF with anorexia, bulimia and age of onset of weight loss in six European populations. Hum Mol Genet. 2004;13:1205-12. (Pubitemid 38877873)
91. Frayling TM, Timpson NJ, Weedon MN, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007;316:889-94. (Pubitemid 46764279)
92. • Hinney A, Nguyen TT, Scherag A, et al. Genome wide association (GWA) study for early onset extreme obesity supports the role of fat mass and obesity associated gene (FTO) variants. PLoS One. 2007;2:e1361. First GWAS for extreme early-onset obesity.
93. Willer CJ, Speliotes EK, Loos RJ, et al. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet. 2009;41:25-34.
94. Speliotes EK, Willer CJ, Berndt SI, et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet. 2010;42:937-48.
95. Jonassaint CR, Szatkiewicz JP, Bulik CM, et al. Absence of association between specific common variants of the obesity-related FTO gene and psychological and behavioral eating disorder phenotypes. Am J Med Genet B Neuropsychiatr Genet. 2011;156B:454-61.
96. Müller TD, Greene BH, Bellodi L, et al. Fat mass and obesity-associated gene (FTO) in eating disorders: evidence for association of the rs9939609 obesity risk allele with bulimia nervosa and anorexia nervosa. Obes Facts. 2012;5:408-19.
97. Hindorff LA, Sethupathy P, Junkins HA, et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A. 2009;106:9362-7.
98. Hebebrand J, Scherag A, Schimmelmann BG, et al. Child and adolescent psychiatric genetics. Eur Child Adolesc Psychiatry. 2010;19:259-79.
99. •• Cross-Disorder Group of the Psychiatric Genomics Consortium, Smoller JW, Craddock N, Kendler K, Lee PH, Neale BM, et al. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet. 2013;381:1371-9. Large-scale cross-disorder analysis of GWAS data.
100. •• Wang K, Zhang H, Bloss CS, et al. A genome-wide association study on common SNPs and rare CNVs in anorexia nervosa. Mol Psychiatry. 2011;16:949-59. A genome-wide association study on common SNPs and rare CNVs in anorexia nervosa.
101. •• Boraska V, Bulik CM, Collier DA, Sullivan PF, Zeggini E, Genetic Consortium for Anorexia Nervosa, Wellcome Trust Case Control Consortium 3. WTCCC3 and GCAN: A genomewide association scan of Anorexia nervosa. Available at: http://www.ashg.org/2012meeting/abstracts/fulltext/f120120381.htm. Accessed 5 Nov 2013. Largest GWAS for AN to date.
102. •• Boraska V, Davis OS, Cherkas LF, et al. Genome-wide association analysis of eating disorder-related symptoms, behaviors, and personality traits. Am J Med Genet B Neuropsychiatr Genet. 2012;159B:803-11. Large population-based GWAS for eating disorder-related traits.
103. Wade TD, Gordon S, Medland S, et al. Genetic variants associated with disordered eating. Int J Eat Disord. 2013;46:594-608.
104. Wermter AK, Laucht M, Schimmelmann BG, et al. From nature versus nurture, via nature and nurture, to gene x environment interaction in mental disorders. Eur Child Adolesc Psychiatry. 2010;19:199-210.
105. Mazzeo SE, Bulik CM. Environmental and genetic risk factors for eating disorders: what the clinician needs to know. Child Adolesc Psychiatr Clin N Am. 2009;18:67-82.
106. Karwautz AF, Wagner G, Waldherr K, et al. Gene-environment interaction in anorexia nervosa: relevance of non-shared environment and the serotonin transporter gene. Mol Psychiatry. 2011;16:590-2.
107. Dempfle A, Scherag A, Hein R, et al. Gene-environment interactions for complex traits: definitions, methodological requirements and challenges. Eur J Hum Genet. 2008;16:1164-72.
108. • Nakabayashi K, Komaki G, Tajima A, et al. Identification of novel candidate loci for anorexia nervosa at 1q41 and 11q22 in Japanese by a genome-wide association analysis with microsatellite markers. J Hum Genet. 2009;54:531-7. First GWAS for AN based on microsatellite markers.
109. Hebebrand J, Bulik C. Critical appraisal of the provisional DSM-5 criteria for anorexia nervosa and an alternative proposal. Int J Eat Disord. 2011;44:665-78.
110. Petronis A. Epigenetics as a unifying principle in the aetiology of complex traits and diseases. Nature. 2010;465:721-7.
111. Relton CL, Davey Smith G. Epigenetic epidemiology of common complex disease: prospects for prediction, prevention, and treatment. PLoS Med. 2010;7:e1000356.
112. Barros SP, Offenbacher S. Epigenetics: connecting environment and genotype to phenotype and disease. J Dent Res. 2009;88:400-8.
113. Berdasco M, Esteller M. Genetic syndromes caused by mutations in epigenetic genes. Hum Genet. 2013;132:359-83.
114. Kuehnen P, Grueters A, Krude H. Two puzzling cases of thyroid dysgenesis. Horm Res. 2009;71(Suppl1):93-7.
115. Kuehnen P, Krude H. Alu elements and human common diseases like obesity. Mob Genet Elem. 2012;2:197-201.
116. Kuehnen P, Mischke M, Wiegand S, et al. An Alu element-associated hypermethylation variant of the POMC gene is associated with childhood obesity. PLoS Genet. 2012;8:e1002543.
117. Stöger R. The thrifty epigenotype: an acquired and heritable predisposition for obesity and diabetes? Bioessays. 2008;30:156-66. (Pubitemid 351196950)
118. Barrès R, Osler ME, Yan J, et al. Non-CpG methylation of the PGC-1alpha promoter through DNMT3B controls mitochondrial density. Cell Metab. 2009;10:189-98.
119. Barrès R, Yan J, Egan B, et al. Acute exercise remodels promoter methylation in human skeletal muscle. Cell Metab. 2012;15:405-11.
120. Barres R, Kirchner H, Rasmussen M, et al. Weight loss after gastric bypass surgery in human obesity remodels promoter methylation. Cell Rep. 2013;3:1020-7.
121. Campbell IC, Mill J, Uher R, et al. Eating disorders, gene-environment interactions and epigenetics. Neurosci Biobehav Rev. 2011;35:784-93.
122. Pjetri E, Dempster E, Collier DA, et al. Quantitative promoter DNA methylation analysis of four candidate genes in anorexia nervosa: a pilot study. J Psychiatr Res. 2013;47:280-2.
123. Steiger H, Labonte B, Groleau P, et al. Methylation of the glucocorticoidreceptor gene promoter in bulimic women: associations with borderline personality disorder, suicidality, and exposure to childhood abuse. Int J Eat Disord. 2013;46:246-55.
124. Frieling H, Gozner A, Römer KD, et al. Global DNA hypomethylation and DNA hypermethylation of the alpha synuclein promoter in females with anorexia nervosa. Mol Psychiatry. 2007;12:229-30. (Pubitemid 46328505)
125. Frieling H, Bleich S, Otten J, et al. Epigenetic downregulation of atrial natriuretic peptide but not vasopressin mRNA expression in females with eating disorders is related to impulsivity. Neuropsychopharmacology. 2008;33:2605-9.
126. Frieling H, Römer KD, Scholz S, et al. Epigenetic dysregulation of dopaminergic genes in eating disorders. Int J Eat Disord. 2010;43:577-83.
127. Ehrlich S, Weiss D, Burghardt R, et al. Promoter specific DNA methylation and gene expression of POMC in acutely underweight and recovered patients with anorexia nervosa. J Psychiatr Res. 2010;44:827-33.
128. • Psychiatric GWAS Consortium Coordinating Committee, Cichon S, Craddock N, et al. Genomewide association studies: history, rationale, and prospects for psychiatric disorders. Am J Psychiatry. 2009;166:540-56. Large international effort to unravel the genetic mechanisms in psychiatric disorders.
129. Maher B. Personal genomes: the case of the missing heritability. Nature. 2008;456:18-21.
130. Easter MM. "Not all my fault": genes, stigma, and personal responsibility for women with eating disorders. Soc Sci Med. 2012;75:1408-16.